GB1489087A - Dithianes and dithiolanes - Google Patents

Dithianes and dithiolanes

Info

Publication number
GB1489087A
GB1489087A GB23144/77A GB2314477A GB1489087A GB 1489087 A GB1489087 A GB 1489087A GB 23144/77 A GB23144/77 A GB 23144/77A GB 2314477 A GB2314477 A GB 2314477A GB 1489087 A GB1489087 A GB 1489087A
Authority
GB
United Kingdom
Prior art keywords
lower alkyl
group
chain
carbon atoms
sulphamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB23144/77A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1489087A publication Critical patent/GB1489087A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

1489087 Dithianes and dithiolanes F HOFFMANN-LA ROCHE & CO AG 20 Dec 1974 [21 Dec 1973] 23144/74 Divided out of 1489086 Heading C2C The invention comprises novel compounds (I), (II) and (III) (including salts thereof) in which n stands for 2 or 3, X<SP>1</SP> represents a sulphur atom or SO 2 , X has the same meaning as X<SP>1</SP> or represents SO, R<SP>1</SP> represents a group of the Formula (IV) in which R<SP>1</SP> 1 , K<SP>1</SP> 2 and R<SP>1</SP> 3 each represent a hydrogen or halogen atom or a lower alkyl group containing 2-6 carbon atoms, a lower alkoxy group containing 2-6 carbon atoms, an aryl-(lower alkoxy), aryloxy, phenyl, nitro, amino, lower alkylthio, trifluoromethyl, hydroxy, cyano, di(lower alkyl)-amino, lower alkanoylamino, carboxyl, lower alkoxycarbonyl, lower alkylsulphonyl, hydroxymethyl, lower alkanoyloxy, amido, lower alkanoyl, sulphamoyl, mono(lower alkyl) sulphamoyl, di(lower alkyl) sulphamoyl, aminocarbonyloxy, mono- (lower alkyl) aminocarbonyloxy, di(lower alkyl) aminocarbonyloxy or (lower alkylamino) -(lower alkyl) group with the proviso that at least one of the symbols R<SP>1</SP> 1 , R<SP>1</SP> 2 and R<SP>1</SP> 3 represents other than a hydrogen atom and that, in the case where two of the symbols R<SP>1</SP> 1 , R<SP>1</SP> 2 and R<SP>1</SP> 3 each represent a hydrogen atom, the third symbol represents other than a halogen atom in the p-position; in which R represents a group of the formula in which R 1 , R 2 and R 3 each represent a hydrogen or halogen atom or a lower alkyl, lower alkoxy, aryl-(lower alkoxy), aryloxy, phenyl, nitro, amino, lower alkylthio, trifluoromethyl, hydroxy, cyano, di(lower alkyl) amino, lower alkanoylamino, carboxyl, lower alkoxycarbonyl, lower alkylsulphonyl, hydroxymethyl, lower alkanoyloxy, amido, lower alkanoyl, sulphamoyl, mono(lower alkyl) sulphamoyl, di- (lower alkyl) sulphamoyl, aminocarbonyloxy, mono(lower alkyl) aminocarbonyloxy, di(lower alkyl) aminocarbonyloxy or (lower alkylamino)- (lower alkyl) group or two adjacent R 1 , R 2 and R 3 symbols together represent a methylenedioxy, ethylenedioxy or butadien-1,3-ylene 1,4 group, R 4 represents a hydrogen atom or a lower alkyl group, R 5 , R 6 and R, each represent a hydrogen or halogen atom or a lower alkyl, lower alkoxy, hydroxy or benzyloxy group or two adjacent R 5 , R 6 and R 7 symbols together represent a methylenedioxy or ethylenedioxy group, Y 1 represents a straight-chain or branched-chain, optionally carbonyl-substituted, aliphatic group containing 2-8 carbon atoms, of which 2-4 carbon atoms are present in the chain, Z 1 represents a straight-chain or branchedchain, optionally carbonyl-substituted, aliphatic group containing 1-8 carbon atoms, of which 1-4 carbon atoms are present in the chain, Y represents a straight-chain or branchedchain, optionally hydroxysubstituted, aliphatic group containing 2-8 carbon atoms, of which 2-4 carbon atoms are present in the chain, Q represents a hydrogen atom and T represents a group of the Formula (VII) or Q represents a radical R in which R has the above-mentioned meaning and T represents a group of the formula in which Z represents a straight-chain or branched - chain, optionally hydroxy - substituted, aliphatic group containing 1-8 carbon atoms, of which 1-4 carbon atoms are present in the chain, m stands for 0 or 1 and A represents the group in which R 4 , R 5 , R 6 and R 7 have the abovementioned meanings and R 8 denotes a leaving atom or group. The groups qualified by lower contain up to 6 carbons and aryl signifies phenyl optionally substituted by halogen, lower alkyl, lower alkoxy, NO 2 and amino, A leaving atom or group is, e.g. halogen, alkyl- or aryl-sulphonyloxy or epoxy. The compounds are made by a variety of standard methods.
GB23144/77A 1973-12-21 1974-12-20 Dithianes and dithiolanes Expired GB1489087A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1803073A CH611614A5 (en) 1973-12-21 1973-12-21 Process for the preparation of heterocyclic compounds

Publications (1)

Publication Number Publication Date
GB1489087A true GB1489087A (en) 1977-10-19

Family

ID=4429892

Family Applications (3)

Application Number Title Priority Date Filing Date
GB23143/77A Expired GB1489088A (en) 1973-12-21 1974-12-20 Aminoketones
GB23144/77A Expired GB1489087A (en) 1973-12-21 1974-12-20 Dithianes and dithiolanes
GB55146/74A Expired GB1489086A (en) 1973-12-21 1974-12-20 Dithiolanes and dithianes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB23143/77A Expired GB1489088A (en) 1973-12-21 1974-12-20 Aminoketones

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB55146/74A Expired GB1489086A (en) 1973-12-21 1974-12-20 Dithiolanes and dithianes

Country Status (24)

Country Link
JP (1) JPS595594B2 (en)
AT (5) AT344693B (en)
AU (1) AU511714B2 (en)
BE (1) BE823625A (en)
CA (4) CA1057295A (en)
CH (3) CH611614A5 (en)
DD (1) DD116829A5 (en)
DE (2) DE2463173C2 (en)
DK (1) DK148323C (en)
ES (5) ES433172A1 (en)
FI (1) FI67216C (en)
FR (1) FR2255064B1 (en)
GB (3) GB1489088A (en)
HK (1) HK43380A (en)
HU (1) HU170429B (en)
IE (1) IE40788B1 (en)
IL (3) IL46146A (en)
LU (1) LU71530A1 (en)
NL (1) NL158496B (en)
NO (1) NO142669C (en)
PH (3) PH19393A (en)
SE (2) SE415763B (en)
YU (1) YU39311B (en)
ZA (1) ZA747526B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515173A1 (en) * 1981-10-28 1983-04-29 Delalande Sa 3-Methoxy 4-alkoxy benzaldehyde(s) - useful as intermediates for antibacterials, esp. trimethoprim and tetroxoprim
JPS60142297U (en) * 1984-02-29 1985-09-20 株式会社豊田自動織機製作所 Rotating device for swiveling driver's seat in forklift
JPS62171328U (en) * 1986-04-23 1987-10-30
DE3642331A1 (en) * 1986-12-11 1988-06-23 Basf Ag BASICLY SUBSTITUTED PHENYL ACETONITRILES, THEIR PRODUCTION AND THE MEDICINAL PRODUCTS CONTAINING THEM
MXPA04006344A (en) * 2001-12-28 2005-03-31 Takeda Pharmaceutical Preventives/remedies for urinary disturbance.
WO2010006103A1 (en) * 2008-07-10 2010-01-14 Ore Pharmaceuticals Inc. Method for enhancing cognition or inhibiting cognitive decline

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds

Also Published As

Publication number Publication date
DE2463173C2 (en) 1987-01-29
IL52843A0 (en) 1977-10-31
GB1489086A (en) 1977-10-19
PH13396A (en) 1980-03-28
CH611614A5 (en) 1979-06-15
HK43380A (en) 1980-08-22
CA1079290A (en) 1980-06-10
IE40788L (en) 1975-06-21
CA1072966A (en) 1980-03-04
SE434746B (en) 1984-08-13
AT350053B (en) 1979-05-10
ES451137A1 (en) 1977-08-16
NL7416507A (en) 1975-06-24
ES451135A1 (en) 1977-08-16
DE2460593A1 (en) 1975-07-03
ZA747526B (en) 1975-12-31
GB1489088A (en) 1977-10-19
ES451136A1 (en) 1977-10-01
ATA38778A (en) 1978-08-15
YU39311B (en) 1984-10-31
DD116829A5 (en) 1975-12-12
NO744615L (en) 1975-07-21
HU170429B (en) 1977-06-28
DE2460593C3 (en) 1979-09-13
FR2255064B1 (en) 1978-03-24
ES451134A1 (en) 1977-08-16
IL52844A0 (en) 1977-10-31
PH13326A (en) 1980-03-13
DK668174A (en) 1975-08-25
AU7600874A (en) 1976-06-03
DE2460593B2 (en) 1979-01-18
FR2255064A1 (en) 1975-07-18
AT344693B (en) 1978-08-10
CA1057295A (en) 1979-06-26
FI352774A (en) 1975-06-22
ATA39178A (en) 1978-08-15
PH19393A (en) 1986-04-07
NO142669B (en) 1980-06-16
BE823625A (en) 1975-06-20
YU336874A (en) 1982-05-31
AU511714B2 (en) 1980-09-04
IE40788B1 (en) 1979-08-15
IL46146A (en) 1980-09-16
DK148323B (en) 1985-06-10
NO142669C (en) 1980-09-24
FI67216C (en) 1985-02-11
DK148323C (en) 1986-03-03
ATA38878A (en) 1978-08-15
JPS5095267A (en) 1975-07-29
AT349013B (en) 1979-03-12
AT349014B (en) 1979-03-12
NL158496B (en) 1978-11-15
SE415763B (en) 1980-10-27
AT349012B (en) 1979-03-12
AU3224278A (en) 1978-05-25
CH620921A5 (en) 1980-12-31
JPS595594B2 (en) 1984-02-06
FI67216B (en) 1984-10-31
SE7416086L (en) 1975-06-23
IL46146A0 (en) 1975-03-13
ATA38978A (en) 1978-10-15
ATA1022674A (en) 1977-12-15
LU71530A1 (en) 1976-11-11
CA1086320A (en) 1980-09-23
CH620920A5 (en) 1980-12-31
ES433172A1 (en) 1977-04-16

Similar Documents

Publication Publication Date Title
GB1473256A (en) Biguanide salts
IL77199A (en) Omega-(polysubstituted inden-2-yl)-3hydroxyaliphatic acid derivatives and delta-lactones thereof,their production and pharmaceutical compositions containing them
GB1355425A (en) Polyalkylene glycol esters of hindered phenolic substituted alkanoic acids as stabilizers
RU96107237A (en) TONERS FOR POLYESTERS
GB1390006A (en) Monoacetals of aromatic 1,2-diketones
GB1489087A (en) Dithianes and dithiolanes
JPS5699340A (en) Color image stabilizing method to provide color fastness to light
ES453264A1 (en) Daunorubicin derivatives
DE3677926D1 (en) ANTIOXIDIZING COMPOUNDS, THEIR PRODUCTION AND THEIR USE.
GB1488430A (en) Imino phthalides
GB1252103A (en)
GB1388180A (en) Acetals
ES8206550A1 (en) 2%-Deoxy-3%,5%-di-O- alkylcarbonyl-5-fluorouridine derivatives, a process for the preparation of the derivatives and anti-tumor agents containing the derivatives
IE37963L (en) Bis-biguanidine salts
GB1455740A (en) Benzylpyrimidine derivatives
GB1168515A (en) Resinous Polymer Compositions and a method for Stabilizing Resinous Polymers
JPS572384A (en) Liquid crystal composition
GB1450862A (en) 6-triazolyl-2-benzofurans and optical brighteners
GB1492380A (en) Substituted trithiolans and their use as flavouring agent
JPS5219614A (en) Process for preparation of crosslinking hardenable compounds
GB1502622A (en) Lubricating oil compositions
JPS5632495A (en) Novel antibiotic, its preparaion, and germicide and acaricide for plant containing the same
JPS5253178A (en) Lubricating grease composition
JPS5239614A (en) Purification process for fatty acid
JPS572385A (en) Liquid crystal composition

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee